Zoryve

Pharma

Arcutis' Zoryve has snagged a 2nd dermatology nod from FDA

About a year after Arcutis Biotherapeutics unveiled positive data on roflumilast foam at a medical congress, the company has clinched a second FDA OK.

Fraiser Kansteiner Dec 15, 2023 7:09pm

Arcutis builds blockbuster case for its new skin disease drug

Nov 16, 2022 10:12am

Arcutis will soon file roflumilast foam for new potential nod

Sep 9, 2022 11:47am

Arcutis launches 'Expose Psoriasis' campaign

Sep 1, 2022 12:00pm